Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07020000 · ClinicalTrials.gov registry record
The Objective of the Protocol is to Generate Real World Evidence (RWE) Supporting the Safety, Performance, and Health Economics of Using the Regulatory Approved and Commercially Available EARP Interbody System Used During Lumbar Interbody Fusion (LIF) Procedures With the EARP Nerve Cuff Electrode
A clinical trial, sponsored by Retropsoas Technologies.
- Not yet
- Registry status
- 120
- Enrollment target
NCT07020000 is a clinical trial that has not yet begun recruiting, run by Retropsoas Technologies. The registered enrollment target is 120 participants.
The verdict
NCT07020000 has not yet begun recruiting, sponsored by Retropsoas Technologies.
- NOT YET RECRUITING
- Registry status
- 120 participants
- Enrollment target
Study Summary
The goal of the trial is to generate data to support the safety, performance, and cost effectiveness of using the EARP devices during Lumbar Interbody Fusion (LIF) procedures. The primary objectives are: * To evaluate the safety of the EARP surgical technique and devices during LIF surgeries. * To understand the EARP fusion system's ability to achieve fusion and improve disk space over time.
Interventions
- DEVICE Device: Nerve Cuff and Retractor System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-08-30 |
| Est. Completion | 2027-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07020000
The ClinicalTrials.gov registry entry for NCT07020000 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Retropsoas Technologies, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Device: Nerve Cuff and Retractor System is the first listed.
NCT07020000 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07020000 about?
NCT07020000 is a clinical study titled "The Objective of the Protocol is to Generate Real World Evidence (RWE) Supporting the Safety, Performance, and Health Economics of Using the Regulatory Approved and Commercially Available EARP Interbody System Used During Lumbar Interbody Fusion (LIF) Procedures With the EARP Nerve Cuff Electrode". The goal of the trial is to generate data to support the safety, performance, and cost effectiveness of using the EARP devices during Lumbar Interbody Fusion (LIF) procedures. The primary objectives are: * To evaluate the safety of the EARP surgical technique and devices during LIF surgeries. * To...
What is the current status of trial NCT07020000?
This trial is currently not yet recruiting. The enrollment target is 120 participants. The study started on 2025-08-30. Estimated completion is 2027-09-30.
What interventions are being tested in trial NCT07020000?
The interventions under investigation include: Device: Nerve Cuff and Retractor System (DEVICE).
Who is sponsoring clinical trial NCT07020000?
This trial is sponsored by Retropsoas Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.